Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: A systematic review

European Journal of Cancer

Volumn 45, Issue 18, 2009, Pages 3124-3130

  van Deurzen, Carolien H M ^a   Vriens, Birgit E P J ^b   Tjan Heijnen, Vivianne C G ^b   van der Wall, Elsken ^a   Albregts, Mirjam ^a   van Hilligersberg, Richard ^a   Monninkhof, Evelyn M ^a   van Diest, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Review; Sentinel lymph node biopsy

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST; BREAST NEOPLASMS; DATABASES, FACTUAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MULTICENTER STUDIES AS TOPIC; NEOADJUVANT THERAPY; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS;

EID: 70450159144     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.08.001     Document Type: Article

References (58)

1. Cure H., Amat S., Penault-Llorca F., et al. Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy. Breast Cancer Res Treat 76 (2002) 37-45
2. Kuerer H.M., Newman L.A., Buzdar A.U., et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg 176 (1998) 502-509
3. Rouzier R., Extra J.M., Klijanienko J., et al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 20 (2002) 1304-1310
4. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 339 (1998) 941-946
5. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
6. Bedrosian I., Reynolds C., Mick R., et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 88 (2000) 2540-2545
7. Chung M.H., Ye W., and Giuliano A.E. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol 8 (2001) 688-692
8. Wong S.L., Chao C., Edwards M.J., et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am Surg 67 (2001) 522-526
9. Lyman G.H., Giuliano A.E., Somerfield M.R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
10. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16 (1998) 2672-2685
11. van der Hage J.A., van de Velde C.J., Julien J.P., Tubiana-Hulin M., Vandervelden C., and Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19 (2001) 4224-4237
12. Mauri D., Pavlidis N., and Ioannidis J.P. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 97 (2005) 188-194
13. Mieog J.S., van der Hage J.A., and van de Velde C.J. Neoadjuvant chemotherapy for operable breast cancer. Br J Surg 94 (2007) 1189-1200
14. Fisher B., Brown A., Mamounas E., Wieand S., et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15 (1997) 2483-2493
15. Bonadonna G., Veronesi U., Brambilla C., et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82 (1990) 1539-1545
16. Fisher B., and Mamounas E.P. Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. J Clin Oncol 13 (1995) 537-540
17. Rietman J.S., Dijkstra P.U., Geertzen J.H., et al. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 11 (2004) 1018-1024
18. Schrenk P., Rieger R., Shamiyeh A., and Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88 (2000) 608-614
19. Kuerer H.M., Sahin A.A., Hunt K.K., et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230 (1999) 72-78
20. Hamza T.H., van Houwelingen H.C., and Stijnen T. The binomial distribution of meta-analysis was preferred to model within-study variability. J Clin Epidemiol 61 (2008) 41-51
21. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9 (1987) 1-30
22. Rothman K.J. Epidemiology. An Introduction (2002), Oxford University Press, New York
23. Nason K.S., Anderson B.O., Byrd D.R., et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 89 (2000) 2187-2194
24. Cohen L.F., Breslin T.M., Kuerer H.M., et al. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol 24 (2000) 1266-1272
25. Fernandez A., Cortes M., Benito E., et al. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun 22 (2001) 361-366
26. Tafra L., Verbanac K.M., and Lannin D.R. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 182 (2001) 312-315
27. Brady E.W. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J 8 (2002) 97-100
28. Stearns V., Ewing C.A., Slack R., et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9 (2002) 235-242
29. Schwartz G.F., and Meltzer A.J. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 9 (2003) 374-379
30. Balch G.C., Mithani S.K., Richards K.R., Beauchamp R.D., and Kelley M.C. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol 10 (2003) 616-621
31. Piato J.R., Barros A.C., Pincerato K.M., Sampaio A.P., and Pinotti J.A. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol 29 (2003) 118-120
32. Vigario A., Sapienza M.T., Sampaio A.P., et al. Primary chemotherapy effect in sentinel node detection in breast cancer. Clin Nucl Med 28 (2003) 553-557
33. Shimazu K., Tamaki Y., Taguchi T., et al. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma. Cancer 100 (2004) 2555-2561
34. Lang J.E., Esserman L.J., Ewing C.A., et al. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg 199 (2004) 856-862
35. Patel N.A., Piper G., Patel J.A., Malay M.B., and Julian T.B. Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer. Am Surg 70 (2004) 696-699
36. Shen J., Gilcrease M.Z., Babiera G.V., et al. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109 (2007) 1255-1263
37. Mamounas E.P., Brown A., Anderson S., et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23 (2005) 2694-2702
38. Jones J.L., Zabicki K., Christian R.L., et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg 190 (2005) 517-520
39. Tanaka Y., Maeda H., Ogawa Y., et al. Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Oncol Rep 15 (2006) 927-931
40. Yu J.C., Hsu G.C., Hsieh C.B., Yu C.P., and Chao T.Y. Role of sentinel lymphadenectomy combined with intraoperative ultrasound in the assessment of locally advanced breast cancer after neoadjuvant chemotherapy. Ann Surg Oncol 14 (2007) 174-180
41. Tausch C., Konstantiniuk P., Kugler F., et al. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol 15 (2008) 3378-3383
42. Kinoshita T. Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy. Breast cancer 14 (2007) 10-15
43. Lee S., Kim E.Y., Kang S.H., et al. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat 102 (2007) 283-288
44. Newman E.A., Sabel M.S., Nees A.V., et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 14 (2007) 2946-2952
45. Yamamoto M., Mehta R.S., Baick C.H., et al. The predictive value of sentinel lymph node biopsy in locally advanced breast cancer patients who have undergone neoadjuvant chemotherapy. Am Surg 73 (2007) 977-980
46. Gimbergues P., Abrial C., Durando X., et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol 15 (2008) 1316-1321
47. Hino M., Sano M., Sato N., and Homma K. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer. Surg Today 38 (2008) 585-591
48. Papa M.Z., Zippel D., Kaufman B., et al. Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer. J Surg Oncol 98 (2008) 403-406
49. Classe J.M., Bordes V., Campion L., et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol 27 (2009) 726-732
50. Krag D.N., Anderson S.J., Julian T.B., et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8 (2007) 881-888
51. Zavagno G., De Salvo G.L., Scalco G., et al. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247 (2008) 207-213
52. Fraile M., Rull M., Julian F.J., et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 11 (2000) 701-705
53. Kim T., Giuliano A.E., and Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106 (2006) 4-16
54. McMasters K.M., Tuttle T.M., Carlson D.J., et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18 (2000) 2560-2566
55. Miltenburg D.M., Miller C., Karamlou T.B., and Brunicardi F.C. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 84 (1999) 138-142
56. Xing Y., Foy M., Cox D.D., et al. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93 (2006) 539-546
57. Kilbride K.E., Lee M.C., Nees A.V., et al. Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence. Ann Surg Oncol 15 (2008) 3252-3258
58. Tanis P.J., Nieweg O.E., Hart A.A., and Kroon B.B. The illusion of the learning phase for lymphatic mapping. Ann Surg Oncol 9 (2002) 142-147